| Role of C-Reactive Protein at Sites of Inflammation and Infection |
163 |
| Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases |
153 |
| Immunosenescence and Inflamm-Aging As Two Sides of the Same Coin: Friends or Foes? |
141 |
| CAR T Cells for Solid Tumors: New Strategies for Finding, Infiltrating, and Surviving in the Tumor Microenvironment |
124 |
| Age and Age-Related Diseases: Role of inflammation Triggers and Cytokines |
112 |
| S100A8/A9 in Inflammation |
106 |
| Macrophage Polarization: Different Gene Signatures in M1(LPS+) vs. Classically and M2(LPS-) vs. Alternatively Activated Macrophages |
102 |
| The Immunology of Macrophage Activation Syndrome |
101 |
| Cold Tumors: A Therapeutic Challenge for Immunotherapy |
99 |
| The Metabolic Signature of Macrophage Responses |
95 |
| Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion |
95 |
| Targeting Myeloid-Derived Suppressor Cells to Bypass Tumor-Induced Immunosuppression |
94 |
| Impact of Obesity on Influenza A Virus Pathogenesis, Immune Response, and Evolution |
87 |
| Debunking the Myth of Exercise-Induced Immune Suppression: Redefining the Impact of Exercise on Immunological Health Across the Lifespan |
83 |
| Extracellular Vesicle Heterogeneity: Subpopulations, Isolation Techniques, and Diverse Functions in Cancer Progression |
82 |
| Past, Present, and Future of Regulatory T Cell Therapy in Transplantation and Autoimmunity |
80 |
| Natural Killer Cells: Development, Maturation, and Clinical Utilization |
79 |
| New Vaccine Technologies to Combat Outbreak Situations |
77 |
| Myeloid-Derived Suppressor Cells Hinder the Anti-Cancer Activity of Immune Checkpoint Inhibitors |
76 |
| Apoptotic Cell-Derived extracellular vesicles: More Than Just Debris |
76 |
| Aspects of Gut Microbiota and Immune System Interactions in Infectious Diseases, Immunopathology, and Cancer |
70 |
| Infectious Disease Threats in the Twenty-First Century: Strengthening the Global Response |
69 |
| A Role for the Krebs Cycle Intermediate Citrate in Metabolic Reprogramming in Innate Immunity and Inflammation |
67 |
| Targeting veGF/veGFR to Modulate Antitumor immunity |
66 |
| The C/EBP Homologous Protein (CHOP) Transcription Factor Functions in Endoplasmic Reticulum Stress-Induced Apoptosis and Microbial Infection |
64 |
| Advances in mRNA Vaccines for Infectious Diseases |
64 |
| Cancer Immunotherapy Based on Natural Killer Cells: Current Progress and New Opportunities |
64 |
| Macrophage Activation-Like Syndrome: A Distinct Entity Leading to Early Death in Sepsis |
63 |
| Host Immune Response to Influenza A Virus Infection |
63 |
| Microglia and Beyond: Innate Immune Cells As Regulators of Brain Development and Behavioral Function |
62 |
| Mesenchymal Stromal Cell Secretome: Influencing Therapeutic Potential by Cellular Pre-conditioning |
62 |
| Immunomodulation by Mesenchymal Stem Cells (MSCs): Mechanisms of Action of Living, Apoptotic, and Dead MSCs |
60 |
| Pharmacological Inhibitors of the NLRP3 Inflammasome |
59 |
| Cell Type-Specific Roles of NF-kappa B Linking Inflammation and Thrombosis |
59 |
| The IL-17 Family of Cytokines in Psoriasis: IL-17A and Beyond |
58 |
| The Dark Side of Fibroblasts: Cancer-Associated Fibroblasts as Mediators of Immunosuppression in the Tumor Microenvironment |
57 |
| Immune Microenvironment in Glioblastoma Subtypes |
56 |
| Targeting Adenosine in Cancer Immunotherapy to Enhance T-Cell Function |
55 |
| Diverse Roles of Mitochondria in Immune Responses: Novel Insights Into Immuno-Metabolism |
54 |
| Influenza A Virus Cell Entry, Replication, Virion Assembly and Movement |
54 |
| Recent Advances in Targeting CD8 T-Cell Immunity for More Effective Cancer Immunotherapy |
54 |
| The Role of indoleamine-3-Dioxygenase in Cancer Development, Diagnostics, and Therapy |
54 |
| Transcriptome of Extracellular Vesicles: State-of-the-Art |
53 |
| Dendritic Cells and CD8 T Cell Immunity in Tumor Microenvironment |
53 |
| Nutrients Mediate Intestinal Bacteria-Mucosal Immune Crosstalk |
53 |
| Mother's Milk: A Purposeful Contribution to the Development of the infant Microbiota and immunity |
53 |
| Targeting B Cell Maturation Antigen (BCMA) in Multiple Myeloma: Potential Uses of BCMA-Based Immunotherapy |
52 |
| LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers |
52 |
| Chemokines and Chemokine Receptors: New Targets for Cancer Immunotherapy |
52 |
| NF-kappa B Signaling in Macrophages: Dynamics, Crosstalk, and Signal Integration |
51 |
